Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Subscribe To Our Newsletter & Stay Updated
